Andexxa effective in GI bleeds

SAN ANTONIO — Andexxa helped produce high rates of hemostasis in patients with major gastrointestinal bleeding, according to study results presented at the American College of Gastroenterology Annual Meeting.“[Andexxa (andexanet alfa, Portola) is a recombinant modified human factor Xa molecule that was specifically designed to reverse the effects of factor Xa inhibitor anticoagulants,” Deborah Siegal, MD, MSc, of McMaster University, said in her presentation.Researchers examined the drug in the ANNEXA-4 trial, a single-arm study comprising 352 patients with acute majorRead More

Share on facebook
Share on twitter
Share on linkedin